Clinical Trials Browser

Phase 2 × INDUSTRY × tilsotolimod × Clear all

NCT02644967 2022-08-03

ILLUMINATE-204

Phase 2 Completed

53 enrolled 21 charts

Melanoma

NCT03865082 2022-02-17

Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor